The First Affiliated Hospital Of University Of Science And Technology Of China
Clinical trials sponsored by The First Affiliated Hospital Of University Of Science And Technology Of China, explained in plain language.
-
Stroke treatment showdown: is removing the clot alone enough?
Disease control CompletedThis study compares two treatments for a severe type of stroke caused by a blockage in a major artery at the base of the brain. Some patients will get a clot-busting drug through a vein followed by a procedure to remove the clot, while others will have the clot removal procedure …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Wrist access may be safer for carotid stenting in major new trial
Disease control CompletedThis study compares two ways to perform carotid artery stenting—a procedure that opens narrowed neck arteries to prevent stroke. The standard method uses an artery in the groin, while the experimental method uses an artery in the wrist. Researchers will enroll 3000 adults with si…
Phase: NA • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New combo treatment could improve outcomes in major stroke
Disease control CompletedThis study tested whether giving a clot-busting drug (tenecteplase) before mechanical clot removal helps people with a severe type of stroke caused by a blockage in the basilar artery. The trial included 330 adults who were treated between 4.5 and 24 hours after stroke symptoms b…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC